Stelerix Web Blog Knowledge at your Fingertips


Trade Traction.

45% of India's USD 22 billiion pharmaceutical industry obtains revenue from exporting generic drugs. Understandably then, it's exciting to see progress in India's trade spat with the EU over generic drugs.

With so much on the line, it makes sense why resolution is important. And an admission of guilt by the EU at this month's Brussels Summit is a concrete and promising step forward.

Comments (0) Trackbacks (0)

No comments yet.

Leave a comment



No trackbacks yet.